Prospective study of blood metabolites associated with colorectal cancer risk
- 26 February 2018
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 143 (3) , 527-534
Abstract
Few prospective studies, and none in Asians, have systematically evaluated the relationship between blood metabolites and colorectal cancer risk. We conducted a nested case–control study to search for risk‐associated metabolite biomarkers for colorectal cancer in an Asian population using blood samples collected prior to cancer diagnosis. Conditional logistic regression was performed to assess associations of metabolites with cancer risk. In this study, we included 250 incident cases with colorectal cancer and individually matched controls nested within two prospective Shanghai cohorts. We found 35 metabolites associated with risk of colorectal cancer after adjusting for multiple comparisons. Among them, 12 metabolites were glycerophospholipids including nine associated with reduced risk of colorectal cancer and three with increased risk [odds ratios per standard deviation increase of transformed metabolites: 0.31–1.98; p values: 0.002–1.25 × 10−10]. The other 23 metabolites associated with colorectal cancer risk included nine lipids other than glycerophospholipid, seven aromatic compounds, five organic acids and four other organic compounds. After mutual adjustment, nine metabolites remained statistically significant for colorectal cancer. Together, these independently associated metabolites can separate cancer cases from controls with an area under the curve of 0.76 for colorectal cancer. We have identified that dysregulation of glycerophospholipids may contribute to risk of colorectal cancer.Keywords
Funding Information
- National Institutes of Health/National Cancer Institute (UM1 CA182910, UM1 CA173640)
- National Key Basic Research Program “973 project” (China) (2015CB554000)
This publication has 25 references indexed in Scilit:
- The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and diseaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 2017
- Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic reviewOncotarget, 2017
- Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic reviewWorld Journal of Gastroenterology, 2015
- Cohort Profile: The Shanghai Men’s Health StudyInternational Journal of Epidemiology, 2015
- Links between metabolism and cancerGenes & Development, 2012
- Toxicology and risk assessment of coumarin: Focus on human dataMolecular Nutrition & Food Research, 2010
- Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk FactorsClinics in Colon and Rectal Surgery, 2009
- Reactive oxygen species: A double-edged sword in oncogenesisWorld Journal of Gastroenterology, 2009
- The Shanghai Women's Health Study: Rationale, Study Design, and Baseline CharacteristicsAmerican Journal of Epidemiology, 2005
- Antitumor Activity of Picolinic Acid in CBA/J Mice23JNCI: Journal of the National Cancer Institute, 1982